‘Treatment of People with Substance Use Disorders with Co-occurring Infections (HIV, HCV, SARS-2, and others)’
Jag H. Khalsa, MS, PhD, DFISAM, currently is serving as a Special Volunteer at National Institute on Drug Abuse, NIH, following retirement in October 2017 after 40 years of US Federal service (10 at FDA and 30 years as the Chief, Medical Consequences of Drug Abuse and Infections Branch, NIDA/NIH); and as an Adjunct Professor in the Department of Microbiology, Immunology, and Tropical Diseases at GWU School of Medicine and Health Sciences, Washington, DC, and Institute of Human Virology, U. Maryland School of Medicine, Baltimore, MD, USA. He is a recipient of numerous meritorious awards including ones from the FDA Commissioner, NIH and NIDA Directors, and several Lifetime Achievement awards in Addiction Science and Addiction Medicine including the Distinguished Fellow of ISAM award. He serves on several editorial boards including the Journal of Addiction Medicine.